Home Tags DB-1324

Tag: DB-1324

GSK and Duality Biologics Sign Option Agreement for DB-1324

GSK and Duality Biologics have entered into an exclusive option agreement for developing and commercializing DB-1324, a potentially best-in-class antibody-drug conjugate (ADC) candidate.